Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
This clinical trial update describes a feasibility study of an immersive virtual reality-based biofeedback intervention for outpatients in r…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat doses of GSK2586184, and the effec…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: On Open-Label Study in Participants With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 open-label study in systemic lupus erythematosus was terminated and results were posted in 2018.
-
FDA approval · 2018-05-15FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved a generic hydroxychloroquine sulfate product from Amneal Pharmaceuticals NY LLC under an original application.
-
CLINICAL_TRIALS withdrawal · 2018-05-11Clinical Trial Update: ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis [Phase 4]
The Phase 4 trial of ACTHAR Gel for membranous lupus nephritis (class V) has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Fatigue, Depression, and Cortical Excitability in Systemic Lupus
An ongoing clinical trial from Assiut University investigates fatigue, depression, and cortical excitability in systemic lupus erythematosus…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Improving Quality of Life for African American Female Adolescents With Lupus [Phase 2]
This clinical trial update describes a Phase 2 study aimed at improving quality of life for African American female adolescents with systemi…
-
FDA approval · 2018-05-08FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved hydroxychloroquine sulfate as a generic drug under an Original Application (ANDA201691) for Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2018-05-01FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for hydroxychloroquine sulfate (generic) from Dr. Reddy's Laboratories Inc. This approval authorizes marketin…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
This completed clinical trial studied health beliefs and health behaviors among minority participants with rheumatic diseases (rheumatoid ar…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography
Terminated clinical trial update from University Hospital Basel evaluating cardiovascular magnetic resonance tomography in patients with sys…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Anti-infection of Low-does IL-2 in SLE [NA]
A completed clinical trial at Peking University People's Hospital evaluating low-dose interleukin-2 for systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: A Complex Contraception Registry
This clinical trial update reports the completion of a complex contraception registry sponsored by the University of California, San Diego, …
-
CLINICAL_TRIALS research · 2018-02-28Clinical Trial Update: Compassionate Use for Subcutaneous (SC) Belimumab
Compassionate-use program for subcutaneous belimumab in systemic lupus erythematosus has been updated; the program is no longer available.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women [NA]
A completed clinical trial evaluating immunogenicity and safety of the HPV vaccine Gardasil in young women with systemic lupus erythematosus…
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis [Phase 3]
A Phase 3 trial evaluating rituximab plus mycophenolate mofetil without oral steroids for lupus nephritis was terminated.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Exploratory Study of DHA in Systemic Lupus Erythematosus Patients [Phase 2]
A Phase 2 exploratory study evaluating docosahexaenoic acid (DHA) in patients with systemic lupus erythematosus is being conducted, with sta…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 [Phase 3]
Continuation Phase 3 trial for lupus patients who completed prior HGS1006 studies completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus [Phase 2]
Phase 2 clinical trial update evaluating subcutaneous treatment for safety and efficacy in generalized systemic lupus erythematosus has comp…
-
CLINICAL_TRIALS research · 2017-12-07Clinical Trial Update: Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy [Phase 4]
A Phase 4 clinical trial update evaluating belimumab's impact on a BLyS activity signature test in systemic lupus erythematosus, without con…
-
CLINICAL_TRIALS withdrawal · 2017-11-27Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating the safety, pharmacokinetics, and pharmacodynamics of the investigational compound JNJ-56022473 in syste…
-
CLINICAL_TRIALS research · 2017-11-21Clinical Trial Update: Scrutinizing the Heterogeneity of SLE: Defining Phenotypes
Clinical trial update focusing on defining phenotypes and heterogeneity within systemic lupus erythematosus to improve subtype characterizat…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 trial assessing safety, tolerability and pharmacokinetics of ABT-199 (venetoclax) in female patients with systemic lupus erythematos…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease [Phase 4]
Phase 4 clinical trial evaluating the immune response to HPV vaccination in patients with autoimmune diseases. The study includes Juvenile I…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Anti-CD20 in Systemic Lupus Erythematosus [Phase 1, Phase 2]
This update notes the completion of a Phase 1/2 clinical trial evaluating an anti-CD20 monoclonal antibody in systemic lupus erythematosus.